Share
New Delhi: Intuitive India, the India arm of Intuitive Surgical, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS), has recently collaborated with top government medical instituitions in India as a part of their initiative to expose next generation surgeons to Robotic-Assisted Surgery.
Intuitive India together with AIIMS Delhi, has developed this educational program called the Intuitive Robotic Onboarding Program and Education (I-ROPE). Through this initiative, Intuitive aims to familiarize resident surgeons with robotic assisted surgery, its technology, clinical applications and its benefits. Currently, Intuitive is driving this program in renowned government medical instituitions in the country, which includes the likes of AIIMS Delhi, AIIMS Bhubaneswar, Dr. Ram Manohar Lohya hospital- Delhi and Armed forces medical college- Pune.
On Medicine
Screening for kidney cancer in Leeds
A new University of Cambridge-led study registered at the ISRCTN registry will investigate the feasibility of developing a full kidney cancer screening clinical trial.
SciePro / stock.adobe.com
Patients taking part in a pioneering lung screening program in Leeds will now have the option to be checked for kidney cancer thanks to additional funding from Yorkshire Cancer Research.
This study, led by Professor Grant Stewart, will investigate whether an extra scan for kidney cancer can be effectively introduced to mobile lung screening programs. The study follows Professor Stewart’s 2020
Around six in 10 people with kidney cancer do not experience symptoms, and they are often only diagnosed during tests for another condition or reason. This means over a third of patients are diagnosed at a late stage when the cancer is more difficult to treat. Just six in 10 patients with kidney cancer live for 5 years after diagnosis.
Medtronic India, in partnership with Docplexus, recently concluded the grand finale of India s Next Sushruta (INS), a case study competition aimed towards post-graduates and super-specialty students in the field of surgery.
Named after the Father of Early Surgery, Sushruta, INS, is a one-of-a-kind industry-academia program in the field of Indian medical technology, which saw participation from across specialties, including Oncology, General Surgery and Gastroenterology.
The finale of this competition saw Dr Usha H, MCh Surgical Oncology from Kidwai Memorial Institute of Oncology, Bangalore, win over the jury with her presentation to claim the title of India s Next Sushruta. Generally, there are not many platforms where young surgeons are encouraged to show their abilities. INS was indeed a great opportunity for every participant all across the country, and thanks to the head of my department, who made sure we participated in this event, said Dr Usha, whe
Date Time
Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
Researchers at The University of Texas MD Anderson Cancer Center have discovered that mutant KRAS and p53, the most frequently mutated genes in pancreatic cancer, interact through the CREB1 protein to promote metastasis and tumor growth. Blocking CREB1 in preclinical models reversed these effects and reduced metastases, suggesting an important new therapeutic target for the deadly cancer.
“To our knowledge, this is the first study to show how these two major genetic drivers work together to promote tumor growth and metastasis,” Kim said. “We learned that signaling downstream of mutant KRAS directly promotes mutant p53 activity. This discovery provides not only a new therapeutic target but unveils a vast transcriptional network that is activated downstream of these mutant proteins.”
Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.